The global clinical microbiology market is projected to reach USD 5.77 billion by 2021 growing at a CAGR of 11.5 percent from 2016 to 2021. In 2016, North America and Europe are expected to be the mature markets for clinical microbiology products. However, Asia-Pacific is expected to become the new revenue-generating pocket in the market in the next five years.
The Asia-Pacific market is projected to grow at the highest CAGR owing to the growing number of hospitals and clinical diagnostic laboratories in India and China; expanding research capabilities for the development of innovative and affordable clinical microbiology testing procedures across India, China, and Japan; and rising incidences of infectious diseases, predicts Markets and Markets. Europe is expected to hold the second-largest share of the global clinical microbiology market in 2016 due to rising acceptance of genome-based diagnostic techniques by healthcare professionals.